Baloch leader Hyrbyair Marri addressed the Pashtun National Council, highlighting the oppression of Baloch and Pashtun communities under Pakistan's rule, including enforced disappearances ...

ISLAMABAD, Jan 23 (Reuters) - Pakistan's former Prime Minister Imran Khan, opens new tab called off reconciliatory talks with the government on Thursday, a week after a court handed him a 14-year ...

He has denied any wrongdoing in all the cases against him, telling Reuters the military - which has ruled Pakistan for most of its history since independence in 1947 - and its intelligence agency ...

Weight loss drugs like Ozempic and wegovy have become global sensation. In the recent years, companies like Novo Nordisk and Eli Lilly have GLP-1 agonists and dual GLP-1/GIP receptor agonists that ...

South Africa vs Pakistan 2nd Test Live Streaming: South Africa are all set to host Pakistan in the second Test of the two-match series on Friday in Cape Town. The Proteas have already gained an ...

In a deal with Islamist parties, Pakistan is abandoning a requirement that religious seminaries, long seen by Western officials as a potential threat, register with the government. By Zia ur ...

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the ...

The hosts have already qualified for the World Test Championship final after beating Pakistan by two wickets in Centurion, and as such, don't necessarily have a bigger picture to play for.

South Africa 615 (Rickelton, Bavuma 106, Verreynne 100, Abbas 3-94) and 61 for no loss (Bedingham 47*) beat Pakistan 194 (Babar 58, Rabada 3-55) and 478 (Masood 145, Babar 81, Rabada 3-115 ...

Once close allies, relations between Pakistan and Afghanistan have soured dramatically — with experts blaming a colonial-era border and a backfired strategy of supporting religious extremists.

According to leading data and analytics company GlobalData, Eli Lilly’s Zepbound (tirzepatide) is poised to surpass Novo Nordisk’s Wegovy (semaglutide), despite expectations for continued ...